메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Yu Rim Lee (Kyungpook National University) Min Kyu Kang (Department of Internal Medicine Yeungnam University College of Medicine) Jeong Eun Song (Department of Internal Medicine Daegu Catholic University School of Medicine) Hyun Jung Kim (Department of Internal Medicine Keimyung University School of Medicine) Young Oh Kweon (Department of Internal Medicine School of Medicine Kyungpook National University) Won Young Tak (Department of Internal Medicine School of Medicine Kyungpook National University) Se Young Jang (Department of Internal Medicine School of Medicine Kyungpook National University) Jung Gil Park (Department of Internal Medicine Yeungnam University College of Medicine) Chang Hyeong Lee (Department of Internal Medicine Daegu Catholic University School of Medicine) Jae Seok Hwang (Department of Internal Medicine Keimyung University School of Medicine) Byoung Kuk Jang (Department of Internal Medicine Keimyung University School of Medicine) Jeong Ill Suh (Dongguk University) Woo Jin Chung (Department of Internal Medicine Keimyung University School of Medicine) Byung Seok Kim (Department of Internal Medicine Daegu Catholic University School of Medicine) Soo Young Park (Department of Internal Medicine School of Medicine Kyungpook National University)
저널정보
대한간학회 Clinical and Molecular Hepatology Clinical and Molecular Hepatology 제26권 제4호
발행연도
2020.1
수록면
562 - 576 (15page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: Although coronavirus disease 2019 (COVID-19) has spread rapidly worldwide, the implication of pre-existing liver disease on the outcome of COVID-19 remains unresolved. Methods: A total of 1,005 patients who were admitted to five tertiary hospitals in South Korea with laboratory-confirmed COVID-19 were included in this study. Clinical outcomes in COVID-19 patients with coexisting liver disease as well as the predictors of disease severity and mortality of COVID-19 were assessed. Results: Of the 47 patients (4.7%) who had liver-related comorbidities, 14 patients (1.4%) had liver cirrhosis. Liver cirrhosis was more common in COVID-19 patients with severe pneumonia than in those with non-severe pneumonia (4.5% vs. 0.9%, P=0.006). Compared to patients without liver cirrhosis, a higher proportion of patients with liver cirrhosis required oxygen therapy; were admitted to the intensive care unit; had septic shock, acute respiratory distress syndrome, or acute kidney injury; and died (P<0.05). The overall survival rate was significantly lower in patients with liver cirrhosis than in those without liver cirrhosis (log-rank test, P=0.003). Along with old age and diabetes, the presence of liver cirrhosis was found to be an independent predictor of severe disease (odds ratio, 4.52; 95% confidence interval [CI], 1.20?17.02; P=0.026) and death (hazard ratio, 2.86; 95% CI, 1.04?9.30; P=0.042) in COVID-19 patients. Conclusions: This study suggests liver cirrhosis is a significant risk factor for COVID-19. Stronger personal protection and more intensive treatment for COVID-19 are recommended in these patients.

목차

등록된 정보가 없습니다.

참고문헌 (29)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0